{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T10:36:51Z","timestamp":1770460611529,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mounting evidence suggests the safety and efficacy of medical marijuana (MM) in treating chronic ailments, including chronic pain, epilepsy, and anorexia. Despite incremental use of medical and recreational cannabinoids, current limited evidence shows generalized unpreparedness of medical providers to discuss or recommend these substances to their patients. Herein, the present study aims to examine internal medicine residents\u2019 knowledge of marijuana and their attitude towards its medical use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a descriptive cross-sectional study. A survey with 12 standardized queries was created and distributed among the internal medicine residents from Mount Sinai Morningside-West (MSMW) program from July 2020 to December 2020. Participants included preliminary and categorical residents from post-graduate years one to three. The survey consisted of self-assessment of residents\u2019 knowledge on the indication, contraindication, adverse effects of MM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eighty-six (59%) out of 145 residents completed the questionnaire. Despite most trainees (70%) having considered certifying the use of MM for their patients, over 90% reported none to little knowledge on its use. Approximately 80% of the surveyed residents expressed willingness to receive an appropriate educational curriculum.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>To the best of our knowledge, this is the first study that indicated a critical lack of medical marijuana-related knowledge in surveyed internal medicine residents. In a population with growing cannabis consumption, physician training on the indication, toxicity, and drug interaction of cannabinoids is warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-022-01651-9","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T16:02:54Z","timestamp":1646323374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Medical marijuana knowledge and attitudes amongst internal medicine residents"],"prefix":"10.1186","volume":"23","author":[{"given":"Iman","family":"Makki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binbin","family":"Zheng-Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maanit","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"publisher","first-page":"117954412090646","DOI":"10.1177\/1179544120906461","volume":"13","author":"H Johal","year":"2020","unstructured":"Johal H, et al. Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord. 2020;13:1179544120906461.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"1651_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejim.2018.01.023","volume":"49","author":"L Bar-Lev Schleider","year":"2018","unstructured":"Bar-Lev Schleider L, et al. Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. Eur J Intern Med. 2018;49:37\u201343.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"1651_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jpainsymman.2017.09.001","volume":"55","author":"AH Lichtman","year":"2018","unstructured":"Lichtman AH, et al. Results of a double-blind, randomized, placebo-controlled study of nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain. J Pain Symptom Manag. 2018;55(2):179\u2013188 e1.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"1651_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12875-019-0906-y","volume":"20","author":"LM Philpot","year":"2019","unstructured":"Philpot LM, Ebbert JO, Hurt RT. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Fam Pract. 2019;20(1):17.","journal-title":"BMC Fam Pract"},{"issue":"4","key":"1651_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11916-011-0208-0","volume":"15","author":"DA Marcus","year":"2011","unstructured":"Marcus DA. Epidemiology of cancer pain. Curr Pain Headache Rep. 2011;15(4):231\u20134.","journal-title":"Curr Pain Headache Rep"},{"key":"1651_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1515\/med-2019-0088","volume":"14","author":"A Sica","year":"2019","unstructured":"Sica A, et al. Cancer- and non-cancer related chronic pain: from the physiopathological basics to management. Open Med. 2019;14:761\u20136.","journal-title":"Open Med"},{"issue":"2","key":"1651_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/ALN.0000000000000963","volume":"124","author":"CJ Hayhurst","year":"2016","unstructured":"Hayhurst CJ, Durieux ME. Differential opioid tolerance and opioid-induced hyperalgesia: a clinical reality. Anesthesiology. 2016;124(2):483\u20138.","journal-title":"Anesthesiology"},{"issue":"10","key":"1651_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/jamainternmed.2020.3285","volume":"180","author":"S Saha","year":"2020","unstructured":"Saha S, Nathani P, Gupta A. Preventing opioid-induced constipation: a teachable moment. JAMA Intern Med. 2020;180(10):1371\u20132.","journal-title":"JAMA Intern Med"},{"key":"1651_CR9","unstructured":"U.S. Surgeon general\u2019s advisory on naloxone and opioid overdose. 2018 [cited 10 Jan 2021]; Available from: https:\/\/www.hhs.gov\/surgeongeneral\/priorities\/opioids-and-addiction\/naloxone-advisory\/index.html."},{"issue":"4","key":"1651_CR10","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1200\/JOP.18.00562","volume":"15","author":"SP Anderson","year":"2019","unstructured":"Anderson SP, et al. Impact of medical cannabis on patient-reported symptoms for patients with cancer enrolled in Minnesota\u2019s Medical Cannabis Program. J Oncol Pract. 2019;15(4):e338\u201345.","journal-title":"J Oncol Pract"},{"issue":"11","key":"1651_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson N, et al. Drug and opioid-involved overdose deaths - United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"1651_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/jamainternmed.2020.0664","volume":"180","author":"A Heinzerling","year":"2020","unstructured":"Heinzerling A, et al. Severe lung injury associated with use of e-cigarette, or vaping, products-California, 2019. JAMA Intern Med. 2020;180(6):861\u20139.","journal-title":"JAMA Intern Med"},{"issue":"36","key":"1651_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.15585\/mmwr.mm6836e2","volume":"68","author":"JG Schier","year":"2019","unstructured":"Schier JG, et al. Severe pulmonary disease associated with electronic-cigarette-product use - interim guidance. MMWR Morb Mortal Wkly Rep. 2019;68(36):787\u201390.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1651_CR14","unstructured":"Outbreak of lung injury associated with the use of E-cigarette, or vaping, products. 2021 [cited 8 Jan 2022]; Available from: https:\/\/www.cdc.gov\/tobacco\/basic_information\/e-cigarettes\/severe-lung-disease.html#latest-information."},{"issue":"7","key":"1651_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cptl.2019.03.006","volume":"11","author":"D Berlekamp","year":"2019","unstructured":"Berlekamp D, et al. Surveys of pharmacy students and pharmacy educators regarding medical marijuana. Curr Pharm Teach Learn. 2019;11(7):669\u201377.","journal-title":"Curr Pharm Teach Learn"},{"key":"1651_CR16","doi-asserted-by":"crossref","unstructured":"Pereira L, et al. Nursing students\u2019 knowledge and attitudes regarding medical marijuana: a descriptive cross-sectional study. Int J Environ Res Public Health. 2020;17(7).","DOI":"10.3390\/ijerph17072492"},{"key":"1651_CR17","unstructured":"Internal medicine certification examination blueprint. 2021 [cited 8 Jan 2022]; Available from: https:\/\/www.abim.org\/Media\/h5whkrfe\/internal-medicine.pdf."},{"key":"1651_CR18","unstructured":"MKSAP 19 features. 2019 [cited 8 Jan 2022]; Available from: https:\/\/www.acponline.org\/featured-products\/mksap-19."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01651-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-022-01651-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01651-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T16:04:41Z","timestamp":1646323481000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-022-01651-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1186\/s12875-022-01651-9","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"assertion":[{"value":"26 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}